Swiss government launches Covid-19 scientific taskforce
A picture made available by the US National Institutes of Health (NIH) shows a transmission electron micrograph of SARS-CoV-2 virus particles, also known as 2019-nCoV, the virus that causes Covid-19, isolated from a patient.
Keystone / Niaid/national Institutes Of Hea
The federal authorities have set up a scientific taskforce to advise the Federal Council and to coordinate national research by universities into coronavirus.
This content was published on
2 minutes
Keystone-SDA/sb
Português
pt
Governo suíço lança força-tarefa contra a Covid-19
The “Covid-19 taskforce” will be led by Matthias Egger, president of the national research council of the Swiss National Science Foundation (SNSF), the government announcedExternal link on Tuesday.
The group will advise the government, interior ministry and other relevant federal and cantonal authorities. It will also identify areas of research and special measures or products that the Swiss scientific community could rapidly contribute to global efforts to fight the virus.
“The Swiss scientific community offers huge potential to have a positive influence on the outcome of the crisis via research, training or knowledge transfer,” the interior ministry said.
It will aim to coordinate coronavirus research being done into diagnostic tests, healthcare, clinical research and contact-tracing via new digital applications, as well as related ethical and legal issues.
More
More
What Swiss researchers are doing to beat Covid-19
This content was published on
Swiss scientists and drug companies are playing an important role in the global effort to develop treatments or a vaccine for the virus.
The taskforce will build on a call by the SNSF on February 25 for proposals on research into coronaviruses “to tackle the current crisis and prepare for future likely epidemics”. A sum of CHF5 million ($5.2 million) has been earmarked for projects.
The SNSF has received 270 applications, according to Swiss public radio, RTS, on Tuesday. The majority of projects were biomedical, including studies of viruses and infections, the immune response in humans and the spread of the disease.
The selected projects “will provide a basis for the subsequent industrial development of active agents”. The grants available are CHF50,000-CHF300,000 per project.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Swiss investigate four people linked to Russian oligarch
This content was published on
The Office of the Attorney General of Switzerland is investigating four individuals linked to Russian oligarch Suleyman Kerimov.
Swiss government scrambles to deal with egg shortage
This content was published on
From September 1, more eggs intended for consumption may be imported into Switzerland. In allowing this, the government wants to secure the supply of eggs for consumers.
This content was published on
Agricultural research sees new development opportunities for Swiss sparkling wines in the face of declining wine consumption. In a survey, half of consumers expressed a willingness to pay more for local products than for foreign ones.
Locarno spotlights filmmakers from South America and Caribbean
This content was published on
The Open Doors section of the Locarno Film Festival has named the winners for 2024. The spotlight is on the South American and Caribbean regions.
Storm paralyses trains to popular Swiss tourist resort
This content was published on
The railway line between Zweilütschinen and Grindelwald in central Switzerland is expected to remain closed until Friday following heavy rains.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
What Swiss researchers are doing to beat Covid-19
This content was published on
Swiss scientists and drug companies are playing an important role in the global effort to develop treatments or a vaccine for the virus.
‘Anti-malaria drug can kill coronavirus’: Novartis chief
This content was published on
Swiss pharmaceutical giant Novartis believes the anti-malaria drug hydroxychloroquine offers one of the best hopes to combat coronavirus.
Covid-19 immunity testing to begin in some Swiss hospitals
This content was published on
The hospitals are planning to roll out testing to evaluate how many people have already been infected, including those who may have already be immune.
Global cooperation needed to prevent Covid-19 drugs ‘free-for-all’
This content was published on
Weaker countries may be pushed aside in the scramble for effective drugs to fight coronavirus, an infectious diseases expert fears.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.